Literature DB >> 19850968

Inflammatory cells regulate p53 and caspases in acute pancreatitis.

Yuji Nakamura1, Jae Hyuk Do, Jingzhen Yuan, Irina V Odinokova, Olga Mareninova, Anna S Gukovskaya, Stephen J Pandol.   

Abstract

The inflammatory response during pancreatitis regulates necrotic and apoptotic rates of parenchymal cells. Neutrophil depletion by use of anti-polymorphonuclear serum (anti-PMN) increases apoptosis in experimental pancreatitis but the mechanism has not been determined. Our study was designed to investigate signaling mechanisms in pancreatic parenchymal cells regulating death responses with neutrophil depletion. Rats were neutrophil depleted with anti-PMN treatment. Then cerulein pancreatitis was induced, followed by measurements of apoptosis signaling pathways. There was greater activation of executioner caspases-3 in the pancreas with anti-PMN treatment compared with control. There were no differences between these groups of animals in mitochondrial cytochrome c release or in activities of initiator caspase-8 and -9. However, there was greater activation of caspase-2 with anti-PMN treatment during cerulein pancreatitis. The upstream regulation of caspases-2 includes p53, which was increased; the p53 negative regulator, Mdm2, was decreased by anti-PMN treatment during cerulein pancreatitis. In vitro experiments using isolated pancreatic acinar cells a pharmacological inhibitor of Mdm2 increased caspase-2/-3 activities, and an inhibitor of p53 decreased these activities during cholecystokinin-8 treatment. Furthermore, experiments using the AR42J cell line Mdm2 small interfering RNA (siRNA) increased caspase-2/-3 activities, and p53 siRNA decreased these activities during cholecystokinin-8 treatment. These results suggest that during acute pancreatitis the inflammatory response inhibits apoptosis. The mechanism of this inhibition involves caspase-2 and its upstream regulation by p53 and Mdm2. Because previous findings indicate that promotion of apoptosis decreases necrosis and severity of pancreatitis, these results suggest that strategies to inhibit Mdm2 or activate p53 will have beneficial effects for treatment of pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850968      PMCID: PMC2806100          DOI: 10.1152/ajpgi.00324.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  51 in total

Review 1.  The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.

Authors:  R M Siegel; F K Chan; H J Chun; M J Lenardo
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 2.  p53-Mdm2--the affair that never ends.

Authors:  Dania Alarcon-Vargas; Ze'ev Ronai
Journal:  Carcinogenesis       Date:  2002-04       Impact factor: 4.944

3.  CD4(+ )T cells play an important role in acute experimental pancreatitis in mice.

Authors:  A Demols; O Le Moine; F Desalle; E Quertinmont; J L Van Laethem; J Devière
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

4.  Caspase 8-mediated cleavage of plectin precedes F-actin breakdown in acinar cells during pancreatitis.

Authors:  Michael Beil; Jürgen Leser; Manfred P Lutz; Anna Gukovskaya; Thomas Seufferlein; Grit Lynch; Stephen J Pandol; Guido Adler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-03       Impact factor: 4.052

5.  Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis.

Authors:  Anna S Gukovskaya; Eva Vaquero; Vjekoslav Zaninovic; Fred S Gorelick; Aldons J Lusis; Marie-Luise Brennan; Steven Holland; Stephen J Pandol
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

Review 6.  Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules.

Authors:  Sudhir Gupta
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

7.  Cholecystokinin induces caspase activation and mitochondrial dysfunction in pancreatic acinar cells. Roles in cell injury processes of pancreatitis.

Authors:  Anna S Gukovskaya; Ilya Gukovsky; Yoon Jung; Michelle Mouria; Stephen J Pandol
Journal:  J Biol Chem       Date:  2002-04-18       Impact factor: 5.157

8.  Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.

Authors:  Frédéric Colland; Etienne Formstecher; Xavier Jacq; Céline Reverdy; Cécile Planquette; Susan Conrath; Virginie Trouplin; Julie Bianchi; Vasily N Aushev; Jacques Camonis; Alessandra Calabrese; Catherine Borg-Capra; Wolfgang Sippl; Vincent Collura; Guillaume Boissy; Jean-Christophe Rain; Philippe Guedat; Rémi Delansorne; Laurent Daviet
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

9.  Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.

Authors:  Patrice Lassus; Ximena Opitz-Araya; Yuri Lazebnik
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

10.  Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis.

Authors:  John D Robertson; Mari Enoksson; Minna Suomela; Boris Zhivotovsky; Sten Orrenius
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  10 in total

Review 1.  Organellar dysfunction in the pathogenesis of pancreatitis.

Authors:  Ilya Gukovsky; Stephen J Pandol; Anna S Gukovskaya
Journal:  Antioxid Redox Signal       Date:  2011-08-11       Impact factor: 8.401

2.  Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.

Authors:  Matthew J DiMagno; Sae-Hong Lee; Chung Owyang; Shi-yi Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

3.  Protective effect of low-molecular-weight heparin on pancreatic encephalopathy in severe acute pancreatic rats.

Authors:  Fu Qiu; Xin-sheng Lu; Yu-kun Huang
Journal:  Inflamm Res       Date:  2012-07-18       Impact factor: 4.575

4.  Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium.

Authors:  Elham Afghani; Stephen J Pandol; Tooru Shimosegawa; Robert Sutton; Bechien U Wu; Santhi Swaroop Vege; Fred Gorelick; Morihisa Hirota; John Windsor; Simon K Lo; Martin L Freeman; Markus M Lerch; Yoshihisa Tsuji; Gil Y Melmed; Wahid Wassef; Julia Mayerle
Journal:  Pancreas       Date:  2015-11       Impact factor: 3.327

Review 5.  Molecular and cellular mechanisms of pancreatic injury.

Authors:  Edwin C Thrower; Fred S Gorelick; Sohail Z Husain
Journal:  Curr Opin Gastroenterol       Date:  2010-09       Impact factor: 3.287

Review 6.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

7.  Resveratrol protects against L-arginine-induced acute necrotizing pancreatitis in mice by enhancing SIRT1-mediated deacetylation of p53 and heat shock factor 1.

Authors:  Nian Wang; Fen Zhang; Liu Yang; Jiang Zou; Hao Wang; Ke Liu; Meidong Liu; Huali Zhang; Xianzhong Xiao; Kangkai Wang
Journal:  Int J Mol Med       Date:  2017-06-06       Impact factor: 4.101

Review 8.  Phytoceuticals in Acute Pancreatitis: Targeting the Balance between Apoptosis and Necrosis.

Authors:  Laura Gaman; Dorin Dragos; Adelina Vlad; Georgiana Catalina Robu; Mugurel Petrinel Radoi; Laura Stroica; Mihaela Badea; Marilena Gilca
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-04       Impact factor: 2.629

9.  Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.

Authors:  Marcus Hollenbach; Sebastian Sonnenberg; Ines Sommerer; Jana Lorenz; Albrecht Hoffmeister
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

Review 10.  Framework for interpretation of trypsin-antitrypsin imbalance and genetic heterogeneity in pancreatitis.

Authors:  Kun Lin; Feng Gao; Qingquan Chen; Qicai Liu; Shu Chen
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.